Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 10-20 16:00:00 EDT

88.16

+2.60

+3.04%

High88.25	Low85.72	Vol672.04M
Open85.72	D1 Closing85.55	Amplitude2.97%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O21.09B	T/O Rate--	Tradable Shares0.00
P/B5.301529	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":88.15757,"timestamp":1792526399999,"preClose":85.55298,"halted":0,"volume":672043392,"delay":0,"changeRate":0.030444,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":2.604591,"latestTime":"10-20 16:00:00 EDT","open":85.71765,"high":88.25371,"low":85.71582,"amount":21089274514.720436,"amplitude":0.029665,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792589400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.301529,"peRate":-32.234021,"turnoverRate":0.019032,"increases":421,"decrements":82,"flats":10,"marketCap":2232650095647.4375,"floatMarketCap":2056296657298.5625},"requestUrl":"/m/hq/s/BK4139/wiki","defaultTab":"wiki","newsList":[{"id":"2677364042","title":"Regeneron Pharmaceuticals, Inc. : TD Cowen Raises Target Price to $980 from $960","url":"https://stock-news.laohu8.com/highlight/detail?id=2677364042","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677364042?lang=en_us&edition=fundamental","pubTime":"2026-10-21 14:23","pubTimestamp":1792563797,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nFWN467106:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU0823416689.USD","LU0058720904.USD","LU0109394709.USD","LU1917777945.USD","LU2324357040.USD","LU2237438978.USD","LU0053666078.USD","LU2362540622.SGD","BK4588","LU0889565916.HKD","LU2468319806.SGD","LU2106854487.HKD","LU2362541513.USD","LU0114720955.EUR","LU1974910355.USD","BBH","LU0823434740.USD","TBXU","LU0882574055.USD","LU0823434583.USD","BK4585","LU0289739699.SGD","REGN","LU2023250504.SGD","LU0320765992.SGD","LU2362541273.HKD","BK4139","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677964640","title":"Lenz Therapeutics, Inc. : TD Cowen Cuts Target Price to $50 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2677964640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677964640?lang=en_us&edition=fundamental","pubTime":"2026-10-21 14:16","pubTimestamp":1792563397,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nFWN4670XE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LENZ","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677647303","title":"Innate Pharma to Highlight Cancer Immunotherapy Pipeline at November Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2677647303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677647303?lang=en_us&edition=fundamental","pubTime":"2026-10-21 13:40","pubTimestamp":1792561218,"startTime":"0","endTime":"0","summary":"Innate Pharma SA ( ($FR:IPH) ) has issued an announcement. Innate Pharma SA said members of its executive team will participate in two upcoming hea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/innate-pharma-to-highlight-cancer-immunotherapy-pipeline-at-november-investor-conferences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/innate-pharma-to-highlight-cancer-immunotherapy-pipeline-at-november-investor-conferences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPHYF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677642917","title":"Alterity Therapeutics Sets Hybrid 2026 AGM, Urges Early Proxy Voting","url":"https://stock-news.laohu8.com/highlight/detail?id=2677642917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677642917?lang=en_us&edition=fundamental","pubTime":"2026-10-21 13:18","pubTimestamp":1792559891,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) just unveiled an update. Alterity Therapeutics has scheduled its 2026 Annual General Meeting of shareholders fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-sets-hybrid-2026-agm-urges-early-proxy-voting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-sets-hybrid-2026-agm-urges-early-proxy-voting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677164292","title":"Alterity Therapeutics Updates CEO Remuneration as Neurodegeneration Programs Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2677164292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677164292?lang=en_us&edition=fundamental","pubTime":"2026-10-21 13:17","pubTimestamp":1792559839,"startTime":"0","endTime":"0","summary":"An update from Alterity Therapeutics ( ($AU:ATH) ) is now available. Alterity Therapeutics has revised the remuneration package for Chief Executive...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-updates-ceo-remuneration-as-neurodegeneration-programs-advance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-updates-ceo-remuneration-as-neurodegeneration-programs-advance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677649007","title":"Shanghai Industrial Urban Development Plans 1.2 Billion Yuan Quasi-REITs Securitization","url":"https://stock-news.laohu8.com/highlight/detail?id=2677649007","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677649007?lang=en_us&edition=fundamental","pubTime":"2026-10-21 11:42","pubTimestamp":1792554122,"startTime":"0","endTime":"0","summary":"Shanghai Industrial Urban Development Group  plans to raise about 1.20 billion yuan through a quasi-REIT asset-backed securitization of a property complex in Wuxi, China, according to a Tuesday Hong Kong bourse filing.Its 59%-owned subsidiary agreed to sell the entire equity interest in Shanghai Chengkai  Wuxi Property for 396 million yuan.The special plan will also provide the target with an 800 million yuan loan to repay its existing shareholder loan.The transaction is expected to increase the group's cash balances and reduce net debt by about 1.17 billion yuan, while generating an unaudited disposal gain of about 55 million yuan.Upon completion, the target will cease to be a subsidiary and its results will no longer be consolidated.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["URE","GRI","BK1240","CLR.SI","TRUR","BPRE","RIET","CFA.SI","SRU.SI","XHOA","00563","SRT.SI","JJJ.SI","BK4007","GLS.SI","BK4139","CFA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130297024","title":"Innovative Drug Stocks Extend Morning Gains as Zai Lab and Everest Medicines Both Rise Over 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130297024","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130297024?lang=en_us&edition=fundamental","pubTime":"2026-10-21 11:00","pubTimestamp":1792551637,"startTime":"0","endTime":"0","summary":"Innovative drug stocks continued their upward momentum in morning trading.As of press time, Zai Lab (09688) rose 5.67% to HK$19.93; Everest Medicines (01952) gained 5.21% to HK$35.56; InnoCare Pharma-B (09606) climbed 2.61% to HK$173; and Akeso (09926) advanced 3.23% to HK$94.35.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4139","IBBQ","06978","01952","BK1161","BK4585","BK1574","ZLAB","LU2488822045.USD","BK4531","BK4588","MEDX","BK1583","09688","LNGR","BK1588","159992","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677498986","title":"Invex Therapeutics Sets Date and Online Access for 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2677498986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677498986?lang=en_us&edition=fundamental","pubTime":"2026-10-21 10:47","pubTimestamp":1792550835,"startTime":"0","endTime":"0","summary":"The latest update is out from Invex Therapeutics Ltd. ( ($AU:IXC) ). Invex Therapeutics has called its 2026 Annual General Meeting of shareholders ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/invex-therapeutics-sets-date-and-online-access-for-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/invex-therapeutics-sets-date-and-online-access-for-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","IXC","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102612614","title":"Ascentage Pharma Shares Rise Over 4% in Early Trading as Lisaftoclax Receives Breakthrough Therapy Designation from Drug Review Center","url":"https://stock-news.laohu8.com/highlight/detail?id=1102612614","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102612614?lang=en_us&edition=fundamental","pubTime":"2026-10-21 10:40","pubTimestamp":1792550415,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (06855) shares rose more than 4% in early trading. As of press time, the stock was up 4.25% at HK$31.86, with a turnover of HK$28.9748 million.On the news front, Ascentage Pharma...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK4139","AAPG","VXUS","KCAI","BK4588","06855","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677646583","title":"FF EAI Robotics Ecosystem Hosts First Investor Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2677646583","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677646583?lang=en_us&edition=fundamental","pubTime":"2026-10-21 10:29","pubTimestamp":1792549767,"startTime":"0","endTime":"0","summary":"FF EAI Robotics Ecosystem Hosts First Investor DayFF EAI Robotics Ecosystem will host its listing ceremony and first Investor Day Oct. 26, 2026, at Nasdaq's MarketSite in New York.Disclaimer:This news","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL9mKJwR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","LU0314104364.USD","NDAQ","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","BK4585","SG9999014021.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","FFR","SG9999014013.SGD","LU2210149790.SGD","BK4139","LU2095319765.USD","SG9999014005.SGD","BCDF","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677646376","title":"Ff Eai Robotics Ecosystem Inc. Announces Details for Its Listing Ceremony and NASDAQ Investor Day, Taking Place on Monday, Oct. 26, at Nasdaq's Marketsite in Nyc","url":"https://stock-news.laohu8.com/highlight/detail?id=2677646376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677646376?lang=en_us&edition=fundamental","pubTime":"2026-10-21 10:28","pubTimestamp":1792549733,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA4ZFRQ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FFR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677717643","title":"Natera Director and Co-Founder Jonathan Sheena Reports Disposal of $603,709.6551 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2677717643","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677717643?lang=en_us&edition=fundamental","pubTime":"2026-10-21 09:35","pubTimestamp":1792546555,"startTime":"0","endTime":"0","summary":"Natera Director and Co-Founder Jonathan Sheena Reports Disposal of $603,709.6551 in Common SharesNatera director and co-founder Jonathan Sheena reported sales of 1,500 common shares through two trusts","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL200g8l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Natera Director and Co-Founder Jonathan Sheena Reports Disposal of $603,709.6551 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0345770308.USD","GNOM","NTRA","LU0106261612.USD","LU2324357040.USD","HELX","LU2065171402.SGD","LU0053671581.USD","LU2264538146.SGD","LU0345770993.USD","LU0012050646.USD","LU0963586101.USD","LU1988902786.USD","LU2065171311.SGD","LU2065731478.USD","LU1064131342.USD","LU2065169927.USD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677436116","title":"Ionis Partner GSK Wins FDA Approval for Hibsago to Treat Chronic Hepatitis B","url":"https://stock-news.laohu8.com/highlight/detail?id=2677436116","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677436116?lang=en_us&edition=fundamental","pubTime":"2026-10-21 09:20","pubTimestamp":1792545649,"startTime":"0","endTime":"0","summary":"Ionis Partner GSK Wins FDA Approval for Hibsago to Treat Chronic Hepatitis BFDA approved GSK’s Hibsago (bepirovirsen), licensed from Ionis Pharmaceuticals, for chronic hepatitis B in eligible adults a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL7XQ4SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677643680","title":"Ionis Partner GSK Announces Hibsago (Bepirovirsen) Approved in the U.S. for the Treatment of Chronic Hepatitis B (Chb)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677643680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677643680?lang=en_us&edition=fundamental","pubTime":"2026-10-21 09:20","pubTimestamp":1792545600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA3YCHHQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677170648","title":"MeiraGTx CFO and COO Richard Giroux Sells $557,200 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2677170648","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677170648?lang=en_us&edition=fundamental","pubTime":"2026-10-21 08:58","pubTimestamp":1792544282,"startTime":"0","endTime":"0","summary":"MeiraGTx CFO and COO Richard Giroux Sells $557,200 in Common SharesMeiraGTx CFO and COO Richard Giroux sold 56,000 ordinary shares on Oct. 20, 2026.The reported sale price was $9.95 per share, leaving","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL8jtQ44:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MeiraGTx CFO and COO Richard Giroux Sells $557,200 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677648196","title":"Disc Medicine Prices Upsized $450 Million Stock Offering at $75 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2677648196","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677648196?lang=en_us&edition=fundamental","pubTime":"2026-10-21 08:52","pubTimestamp":1792543950,"startTime":"0","endTime":"0","summary":"Disc Medicine Prices Upsized $450 Million Stock Offering at $75 a ShareDisc Medicine priced an upsized public offering of common stock expected to raise $450 million in gross proceeds before expenses.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL6FknlG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BGHQF748.EUR","IRON","NDAQ","BK4139","IE00BN0W2T93.GBP","SG9999014013.SGD","LU0053671581.USD","BK4585","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014021.USD","BK4112","IE00BQXX3F31.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2W23.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677648198","title":"Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2677648198","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677648198?lang=en_us&edition=fundamental","pubTime":"2026-10-21 08:52","pubTimestamp":1792543930,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA5YSVW4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IRON","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677193648","title":"Disc Medicine - Selling 6,000,000 Shares at $75 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2677193648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677193648?lang=en_us&edition=fundamental","pubTime":"2026-10-21 08:52","pubTimestamp":1792543930,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA5YSVW4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRON","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677486416","title":"Oruka Therapeutics General Counsel Paul T Quinlan Sells $706,734.83 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2677486416","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677486416?lang=en_us&edition=fundamental","pubTime":"2026-10-21 08:43","pubTimestamp":1792543398,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics General Counsel Paul T Quinlan Sells $706,734.83 in Common SharesOruka Therapeutics General Counsel Paul T. Quinlan sold 9,000 common shares on October 20, 2026, according to a Form","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL3ZBfpM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Oruka Therapeutics General Counsel Paul T Quinlan Sells $706,734.83 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0320765992.SGD","BK4139","ORKA","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161420001","title":"ETF Daily | BBUL Surges 17%; XPEG Jumps 15%; MRNX Rallies 13%; BMNU, ASSX Gain 12%; Small Caps and Real Estate Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1161420001","media":"ETF Tracker","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161420001?lang=en_us&edition=fundamental","pubTime":"2026-10-21 08:30","pubTimestamp":1792542600,"startTime":"0","endTime":"0","summary":"Market OverviewOn Tuesday, Oct 20, the Dow Jones Industrial Average rose 1.02%, the S&P 500 added 0.28%, and the Nasdaq Composite slipped 0.02%.ETF trading skewed risk-on, with leveraged equity...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e426da9b0703426f963fa150b0854bd3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBSB","LU2095319765.USD","DIA","FLGV","ISHG","IEI","UGL","BMNU","EVS.SI","BAR","BK4139","SG9999014013.SGD","LU2210149790.SGD","SGOL","GLDY","WDNA","BBIB","TWM","OUNZ","DULL","TFJL","SMTG","IE00BQXX3F31.USD","GNOM","EOSE","MRNX","TLTW","DOG","IE00B3QW5Z07.USD","ITB","BK4551","BK4588","ICVT","TLTX","BK7095","DRV","IE00BN0W2V16.EUR","IWM","RWM","IGLD","SPTL","SHV","BK4099","MRNA","SGOV","XPEV","BK4082","BCDF","BNMC","EO","VTWO","YGLD","FAS","IEF","SG9999014005.SGD","URTY","LU1303367103.USD","DXD","ASST","LU0205193047.USD","TSEU","IE0009354923.USD","BK4532","SG9999014039.USD","IE00BKPKM429.USD","XSMO","BBUL","BBLB","TNA","DBB","IBB","BK4585","AGQ","SPLB","BMNG","TLT","IE00BN0W2W23.USD","SDOW","LGHT","LU2360107168.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4097","BK4023","TUR","TBJL","BGLD","GLL","TLH","DDM","BK4550","WZRD","BK4555","BK4568","BK4501","BK4112","IE00BGHQF748.EUR","BK4547","BWZ","SIVR","LUMA","SHY","LU1861215975.USD","DZZ","USSX","XPEG","IAUI","BK4534","GDXY","NUGT","LU2098885051.SGD","LU0314104364.USD","UWM","BWX","BK4526","BMNR","BK4581","FGDL","LU1861220033.SGD","ZSL","IE00BN0W2T93.GBP","IDNA","IE00BQXX3D17.EUR","LU0012050646.USD","USG","DRN","BK4141","IAU","URE","YBMN","BMNZ","LAZR","IGOV","TSYW","LU0205194284.USD","TSEM","BB","VCLT","LU2290526834.HKD","BK4505","SLV","TLTI","TZA","GLD","FDN","DUST","KGLD","GLDM","BK4009","BK4533","SG9999014021.USD","SHNY","LU2210150020.SGD","BK4135","BK4548","TSEG","LU0106261612.USD","UDOW","ASSX","AAAU","BRZU","DGZ","MRNY","IAUM","GDXW","DGP","EWZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0115},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.029},{"period":"6month","weight":0.0855},{"period":"1year","weight":0.1456},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}